05.07.2012

The AEB Health and Pharmaceuticals Committee had a meeting with Timofey Nizhegorodtsev in the office of the Federal Antimonopoly Service on July 4, 2012. The representatives of Novo Nordisk, Ferring Pharmaceuticals, Alcon, Merck, Stada, Teva, Esparma GmbH, Servier, Boiron and AEB Coordinator for Health and Pharmaceuticals Committee participated in the meeting.
 

During more than one hour meeting, the following issues were discussed: harmonization of the Russian and European regulatory systems in the healthcare and pharmaceutical fields, including drug healthcare policy-related issues – essential drug list formation, treatment standards, and developing GMP standards for pharmaceutical industry in Russia.  Mr. Nizhegorodtsev and the Committee members agreed to continue discussion on the respective important issues related to pharmaceutical industry and healthcare.